Navigation Links
Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Date:5/11/2009

RED-CABG Trial Initiates Patient Recruitment for Potentially Life-Saving Agent

KENILWORTH, N.J., May 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the start of patient enrollment in RED-CABG, the Phase 3 Trial for acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA). Acadesine was licensed from PeriCor Therapeutics, Inc., a privately held specialty biopharmaceutical company. Acadesine is being studied as intravenous infusion for the prevention of ischemia-reperfusion injury, a complication of cardiac surgery in patients undergoing coronary artery bypass graft (CABG) surgery using cardiopulmonary bypass (a procedure that stops the heart and places the patient on a pump).

"Ischemia-reperfusion injury represents a serious and life-threatening cardiac surgery complication in patients undergoing coronary artery bypass surgery performed with cardiopulmonary bypass, and there are currently no approved treatments," stated Robert Harrington, M.D., Director of the Duke Clinical Research Institute, and Study Chair of the trial.

Although CABG surgical techniques have improved and reduced procedural morbidity and mortality, complication rates resulting from these procedures, such as ischemia-reperfusion injury, remain unacceptably high. According to a national cardiac surgery database from the Society of Thoracic Surgeons, there is a 30-day operative mortality and major complication rate of 13.4 percent associated with the CABG procedure. In addition, an agent that can be shown to reduce surgical complications can potentially have a significant impact on healthcare costs.

"We are pleased to be initiating the RED-CABG Phase 3 clinical trial for acadesine, which has the potential to reduce perioperative complications in patients un
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Schering-Plough Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Largest in N.J., North America
2. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
3. Schering-Plough Reports Financial Results for 2009 First Quarter
4. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
5. Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
6. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
7. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
8. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
9. Schering-Plough Selects Benefit Advocates for Health Advocacy
10. Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
11. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – ... current treatment landscape, unmet needs, current pipeline and commercial ... anti-cancer drug which is typically used for treating colorectal ... for treating gastric cancer and pancreatic cancer. TS-1 is ... was first approved in 1999 in Japan for the ...
(Date:12/25/2014)... the popular online supplier of wedding dresses and special occasion ... black one-shoulder cocktail dresses . In addition, all these elegant ... prices, up to 70% off. , The development ... You know, we have thousands of frequent callers in the ... can visit our website for more details. The current special ...
(Date:12/25/2014)... Recently, BellasDress has launched its ... dresses. BellasDress has chosen their best-selling lace wedding dresses, ... the holiday season. , Now, BellasDress.com features popular ... here at discount prices. The business hopes everyone can ... , “All our elegant products are made ...
(Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... --, -- Management expects to report revenues of approximately, ... the Fiscal Year which ends June 30, 2009. ... approximately $12.4 million and, $1.8 million, respectively., ... $10.5 million in net income, representing approximately 40%, ...
... Hospital Home Health and Hospice Services, the oldest homecare ... entered into a business relationship with Cardiocom (R) ... chronic illness. Cardiocom, the Experts in Telehealth(SM), is ... of award-winning telehealth solutions. , , Cardiocom,s telehealth ...
... , DOYLESTOWN, Pa., June 18 The Quigley Corporation, ... announced that Ted Karkus, Chairman of the Board of The Quigley ... of Directors of the Company. Mr. Karkus will serve in this ... rate of $5,000 per week for his services. , , ...
... NEW YORK , June 18 HLTH Corporation (Nasdaq: ... (Nasdaq: WBMD ), announced today that they have entered ... into WebMD in a tax-free, all-stock transaction. WebMD will be ... serve as Chairman of the Board and Wayne Gattinella will serve ...
... June 18 Multitask Productions LLC is changing the way you ... community featuring dynamic videos of exercises and a content-rich blog designed ... daily routine. , , , From doing ... toned thighs, SqueezeItIn.com shows you how to make fitness fit into ...
... Group, Inc. (Nasdaq: ENSG ), the parent company ... and assisted living companies, announced today that its Board of ... share of Ensign common stock, payable on or before July ... 2009. Ensign has been a dividend-paying company since 2002. ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 2Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 3Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 4Health News:Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance 5Health News:Englewood Hospital Home Health and Hospice Services Selects Cardiocom Telehealth Technology 2Health News:Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation 2Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 2Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 3Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 4Health News:HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge 5Health News:New Fitness Website Offers a No Gym, No Equipment, No Excuses Workout Solution: SqueezeItIn.com Challenges You to Let Life Be Your Workout 2
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced it ... MigraPure® H, a hemp-based, advanced headache relief product, for ... in Colorado , Washington ... With the MigraPure H Advanced headache relief ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... & Melinda Gates Foundation today announced that Dr. Trevor Mundel ... Mundel, who is currently global head of development for Novartis ... work at the foundation on December 1. "We ... our global health program," said Bill Gates, co-chair of the ...
... Inc. is pleased to announce its exclusive agreement with ... automated FIT product, a fecal occult blood analyzer that ... the early detection of colorectal cancer. The agreement includes ... and OC-Sensor Diana, a high throughput automated FIT analyzer, ...
Cached Medicine Technology:Gates Foundation Names Dr. Trevor Mundel to Lead Global Health Program 2Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market 2
Inquire...
...
... is your system. CONMED's family of products ... New, state-of-the art generators feature proprietary Energy ... continuous synchronization of current and voltage in ... enables the system to sample current and ...
... PoliPhase® is a biologically based adhesive ... component system consisting of a liquid ... control of internal bleeding. ... flow on to a prepared wound ...
Medicine Products: